2011
Performance of everolimus-eluting and paclitaxel-eluting coronary stents in women: 2-year outcomes from the SPIRIT IV trial
Lansky A, Yaqub M, Sood P, Ying S, Wang J, Caputo R, Farhat N, Applegate R, Skelding K, Kereiakes D, Sudhir K, Stone G. Performance of everolimus-eluting and paclitaxel-eluting coronary stents in women: 2-year outcomes from the SPIRIT IV trial. Cardiovascular Revascularization Medicine 2011, 12: e9. DOI: 10.1016/j.carrev.2011.04.267.Peer-Reviewed Original Research
2010
One-year outcomes of everolimus-eluting and paclitaxel-eluting coronary stents in women: analysis from the Spirit IV Trial
Lansky A, Wang J, Kereiakes D, Sood P, Yaqub M, Shih-Wa Y, Simonton C, Caputo R, Applegate R, Stone G. One-year outcomes of everolimus-eluting and paclitaxel-eluting coronary stents in women: analysis from the Spirit IV Trial. Cardiovascular Revascularization Medicine 2010, 11: 277-278. DOI: 10.1016/j.carrev.2010.03.029.Peer-Reviewed Original ResearchComparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial.
Applegate RJ, Hermiller JJ, Sanz M, Doostzadeh J, Pierson W, Su X, Lansky AJ, Sudhir K, Stone GW. Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial. EuroIntervention 2010, 6: 437-46. PMID: 20884430, DOI: 10.4244/eij30v6i4a75.Peer-Reviewed Original ResearchConceptsPaclitaxel-eluting stentsClinical outcomesStent typeMajor adverse cardiac eventsTwo-year event ratesSPIRIT IIIPaclitaxel-eluting coronary stentsSPIRIT III trialYear clinical outcomesAdverse cardiac eventsCardiac eventsIII trialsPE groupTwo-vesselPatientsEvent ratesCoronary stentsTrialsVessel treatmentStentsOutcomesVesselsSignificant interactionStentingLesionsCOMPARISON OF EVEROLIMUS-ELUTING AND PACLITAXEL-ELUTING CORONARY STENTS IN PATIENTS UNDERGOING MULTI-VESSEL STENTING: POOLED ANALYSIS FROM THE SPIRIT III AND SPIRIT IV RANDOMIZED TRIALS
Kereiakes D, Sudhir K, Hermiller J, Lansky A, Doostzadeh J, Pierson W, Su X, Gordon P, Stone G. COMPARISON OF EVEROLIMUS-ELUTING AND PACLITAXEL-ELUTING CORONARY STENTS IN PATIENTS UNDERGOING MULTI-VESSEL STENTING: POOLED ANALYSIS FROM THE SPIRIT III AND SPIRIT IV RANDOMIZED TRIALS. Journal Of The American College Of Cardiology 2010, 55: a140.e1317. DOI: 10.1016/s0735-1097(10)61318-6.Peer-Reviewed Original ResearchPaclitaxel-eluting coronary stentsMulti-vessel stentingEverolimus-ElutingRandomized trialsPooled analysisCoronary stents